Conditons Treated	Prevention & Screening
Cure and Care	Detection, Diagnosis, & Statging

Every year, more than 260,000 cases of gastrointestinal cancer (GI cancer) are diagnosed in the United States. Even more people suffer from GI conditions that are precursors of cancer and can remain silent for a long time, such as Gastro-Esophageal Reflux Disease, or GERD (19 million), inflammatory bowel disease (600,000), and Barrett’s esophagus (700,000).

That’s why Beth Israel Medical Center has created the GastroIntestinal Institute (GII). Working in collaboration with the Medical Center’s Department of Digestive Disease, which addresses common GI ailments, GII is an advanced center focusing on precancerous and cancerous GI conditions.

Beth Israel’s Sol and Margaret Berger GI Cancer Suite is located at Phillips Ambulatory Care Center, 10 Union Square East, in Manhattan. GII offers patients comprehensive evaluations, cutting-edge diagnostics and innovative procedures to treat the full array of these diseases.

Additionally, the institute taps into all the medical expertise Beth Israel has to offer. The Medical Center is one of five distinguished New York City hospitals managed by the nonprofit Continuum Health Partners system, and it serves as the Manhattan campus for the Albert Einstein College of Medicine.

As with any disease, where a patient first chooses to receive care can make a crucial difference in achieving a cure. GII strives to provide the best cure rates and lowest rates of recurrence, while always seeking to preserve internal organs, bodily functions and quality of life.

If you would like a referral to a physician who specializes in gastrointestinal conditions and diseases, please call Beth Israel’s Referral Service at 800-753-3229